RGNX
NASDAQStockREGENXBIO Inc.
$8.47-0.61 (-6.72%)
52-Week Range
$5.31
$15.98
Key Stats
Market Cap
428.8M
P/E Ratio
—
Dividend Yield
—
Beta
1.14
Volume
807.6K
Avg Volume
1.0M
Performance
1M
+8.74%
3M
-34.35%
6M
-0.11%
YTD
-33.09%
1Y
+35.12%
3Y
-56.37%
5Y
-78.26%
Price Chart
ETF Exposure
RGNX is held by 85 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| WDNA.L | WisdomTree BioRevolution UCITS ETF - USD Acc | 1.59% |
| WDNA | WisdomTree BioRevolution Fund | 1.35% |
| IBRN | iShares Neuroscience and Healthcare ETF | 0.59% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.51% |
| GNOG.L | Global X - Genomics & Biotechnology UCITS ETF | 0.40% |
| GNOM.L | Global X - Genomics & Biotechnology UCITS ETF | 0.40% |
| HAPS | Harbor Human Capital Factor US Small Cap ETF (HAPS) | 0.32% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.32% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.30% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.29% |
| SAGP | Strategas Global Policy Opportunities ETF | 0.27% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.21% |
| DMRS | DeltaShares S&P 600 Managed Risk ETF | 0.17% |
| FSML | Franklin Small Cap Enhanced ETF | 0.14% |
| STSB | iShares Factors US Small Blend Style ETF | 0.12% |
| CURE.AX | Global X - S&P Biotech ETF | 0.12% |
| XBI | State Street SPDR S&P Biotech ETF | 0.12% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.10% |
| SLY | SPDR S&P 600 Small Cap ETF | 0.10% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.07% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.06% |
| GINN | Goldman Sachs Innovate Equity ETF | 0.05% |
| DRDR.L | iShares Healthcare Innovation UCITS ETF | 0.05% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.05% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.05% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.05% |
| 2B77.DE | iShares Ageing Population UCITS ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.04% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.04% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.04% |
| PWS | Pacer WealthShield ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.03% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
Page 1 of 2Next
About RGNX ETF Exposure
REGENXBIO Inc. (RGNX) is held by 85 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 428.8M, RGNX is a widely held institutional stock. The stock currently trades at $8.47. Investors can gain exposure to RGNX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RGNX, sorted by portfolio weight.